(S (NP (RB Early) (NN diagnosis)) (VP (VBZ is) (ADJP (JJ important) (PP (IN for) (NP (NML (NN type) (CD 2)) (NN diabetes) (PRN (-LRB- -LRB-) (NP (NN T2D)) (-RRB- -RRB-))))) (S (VP (TO to) (VP (VP (VB improve) (NP (JJ patient) (NN prognosis))) (, ,) (VP (VB prevent) (NP (NNS complications))) (CC and) (VP (VB reduce) (NP (NML (JJ long) (HYPH -) (NN term)) (NN treatment) (NNS costs))))))) (. .))
(S (NP (PRP We)) (VP (VBP present) (NP (DT a) (JJ novel) (NML (NN risk) (NN profiling)) (NN approach)) (PP (VBN based) (PP (ADVP (RB exclusively)) (IN on) (NP (NP (NML (NN health) (NN expenditure)) (NNS data)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ available) (PP (IN to) (NP (JJ Belgian) (NML (JJ mutual) (NN health)) (NNS insurers))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD used) (NP (NP (NN expenditure) (NNS data)) (VP (VBN related) (PP (IN to) (NP (NP (NN drug) (NNS purchases)) (CC and) (NP (JJ medical) (NNS provisions)))) (S (VP (TO to) (VP (VB construct) (NP (NP (NNS models)) (SBAR (WHNP (WDT that)) (S (VP (VBP predict) (SBAR (IN whether) (S (NP (DT a) (NN patient)) (VP (MD will) (VP (VB start) (NP (NP (ADJP (NN glucose) (HYPH -) (VBG lowering)) (NN pharmacotherapy)) (PP (IN in) (NP (DT the) (VBG coming) (NNS years))))))))))))))))) (, ,) (PP (VBN based) (PP (IN on) (NP (NP (DT that) (NN patient) (POS 's)) (JJ recent) (NML (JJ medical) (NN expenditure)) (NN history))))) (. .))
(S (S (NP (NP (DT The) (NN design) (CC and) (NN implementation)) (PP (IN of) (NP (DT the) (NN modeling) (NN strategy)))) (VP (VBP are) (VP (VBN discussed) (PP (IN in) (NP (NN detail)))))) (CC and) (S (NP (JJ several) (NN learning) (NNS methods)) (VP (VBP are) (VP (VBN benchmarked) (PP (IN for) (NP (PRP$ our) (NN application)))))) (. .))
(S (NP (PRP$ Our) (ADJP (JJS best) (VBG performing)) (NN model)) (VP (VBZ obtains) (SBAR (S (NP (NP (NP (QP (IN between) (CD 74.9) (NN %) (CC and) (CD 76.8) (NN %)) (NN area)) (PP (IN under) (NP (DT the) (NNP ROC) (NN curve)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ comparable) (PP (IN to) (NP (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (NN risk) (NN prediction)))))))) (VP (VBZ approaches) (PP (IN for) (NP (NN T2D))) (PP (VBN based) (PP (IN on) (NP (NNS questionnaires)))))))) (. .))
(S (PP (IN In) (NP (NP (NN contrast)) (PP (IN to) (NP (JJ other) (NNS methods))))) (, ,) (NP (PRP$ our) (NN approach)) (VP (MD can) (VP (VB be) (VP (VBN implemented) (PP (IN on) (NP (NP (DT a) (ADJP (NN population) (HYPH -) (JJ wide)) (NN scale)) (PP (IN at) (NP (RB virtually) (DT no) (JJ extra) (JJ operational) (NN cost)))))))) (. .))
(S (ADVP (RB Possibly)) (, ,) (NP (PRP$ our) (NN approach)) (VP (MD can) (VP (VB be) (ADVP (RB further)) (VP (VBN improved) (PP (IN by) (NP (JJ additional) (NN information))) (PP (IN about) (NP (NP (DT some) (NN risk) (NNS factors)) (PP (IN of) (NP (NP (NN T2D)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ unavailable) (PP (IN in) (NP (NML (NN health) (NN expenditure)) (NNS data)))))))))))))) (. .))
